Litcius/Paper detail

Enhanced colon-targeted drug delivery through development of 5-fluorouracil-loaded cross-linked mastic gum nanoparticles

Umme Hani, Nawaz Mahammed, T Reshma, Sirajunisa Talath, Adil Farooq Wali, Asma M. Al-Jasser, Adel Al Fatease, Ali H. Alamri, Sharuk L. Khan

2025Scientific Reports16 citationsDOIOpen Access PDF

Abstract

This study explored the development of a novel colon-specific drug delivery system for 5-fluorouracil (5-FU) using cross-linked mastic gum (MG) nanoparticles (NPs). The primary goal is to enhance the treatment efficacy of colon cancer while minimizing systemic side effects. We employed Fourier Transform Infrared Radiation (FTIR) and Scanning Electron Microscopy (SEM) for the detailed characterization of the samples. FTIR analysis confirmed the successful cross-linking of MG, whereas SEM images revealed the spherical and uniform morphology of the NPs. Additionally, analysis of drug encapsulation efficiency (83.53%), particle size (240 nm), and drug release kinetics (zero-order), and the drug release percentage (95.20% ) were analyzed. The results demonstrated that MG NPs effectively encapsulated and controlled the release of 5-FU in a colon-targeted manner. This study recommends the proposed drug delivery system because of its potential to improve the outcomes of colon cancer treatment.

Topics & Concepts

FluorouracilDrug deliveryNanoparticleDrugPharmacologyChemistryMedicineNanotechnologySurgeryMaterials scienceChemotherapyNanoparticle-Based Drug DeliveryAdvanced Drug Delivery SystemsDrug Solubulity and Delivery Systems
Enhanced colon-targeted drug delivery through development of 5-fluorouracil-loaded cross-linked mastic gum nanoparticles | Litcius